Back to Journals » Core Evidence

Core Evidence


Journal Articles:

- 130 records -

Canagliflozin in the treatment of type 2 diabetes: an evidence-based review of its place in therapy

Karagiannis T, Bekiari E, Tsapas A

Core Evidence 2017, 12:1-10

Published Date: 15 March 2017

Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy

Tonin FS, Wiens A, Fernandez-Llimos F, Pontarolo R

Core Evidence 2016, 11:49-61

Published Date: 14 December 2016

Imiglucerase in the management of Gaucher disease type 1: an evidence-based review of its place in therapy

Serratrice C, Carballo S, Serratrice J, Stirnemann J

Core Evidence 2016, 11:37-47

Published Date: 14 October 2016

Everolimus in the management of metastatic renal cell carcinoma: an evidence-based review of its place in therapy

Buti S, Leonetti A, Dallatomasina A, Bersanelli M

Core Evidence 2016, 11:23-36

Published Date: 1 September 2016

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy

Margaritopoulos GA, Vasarmidi E, Antoniou KM

Core Evidence 2016, 11:11-22

Published Date: 1 July 2016

Clinical utility of tadalafil in the treatment of pulmonary arterial hypertension: an evidence-based review

Henrie AM, Nawarskas JJ, Anderson JR

Core Evidence 2015, 10:99-109

Published Date: 2 November 2015

Nintedanib: evidence for its therapeutic potential in idiopathic pulmonary fibrosis

Inomata M, Nishioka Y, Azuma A

Core Evidence 2015, 10:89-98

Published Date: 27 August 2015

Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy

Dinnel J, Moore BL, Skiver BM, Bose P

Core Evidence 2015, 10:23-38

Published Date: 13 January 2015

Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes

Edwards KL, Minze MG

Core Evidence 2015, 10:11-21

Published Date: 9 January 2015

Sipuleucel-T in the treatment of prostate cancer: an evidence-based review of its place in therapy

Graff JN, Chamberlain ED

Core Evidence 2015, 10:1-10

Published Date: 18 December 2014

Luliconazole for the treatment of fungal infections: an evidence-based review

Khanna D, Bharti S

Core Evidence 2014, 9:113-124

Published Date: 24 September 2014

Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis

Coimbra S, Figueiredo A, Santos-Silva A

Core Evidence 2014, 9:89-97

Published Date: 21 July 2014

Clinical utility of treprostinil in the treatment of pulmonary arterial hypertension: an evidence-based review

Buckley MS, Berry AJ, Kazem NH, Patel SA, Librodo PA

Core Evidence 2014, 9:71-80

Published Date: 20 June 2014

Development of cabozantinib for the treatment of prostate cancer [Corrigendum]

Vaishampayan UN

Core Evidence 2014, 9:69-70

Published Date: 16 May 2014

Development of cabozantinib for the treatment of prostate cancer

Vaishampayan UN

Core Evidence 2014, 9:61-67

Published Date: 23 April 2014

Eptifibatide: The evidence for its role in the management of acute coronary syndromes [Corrigendum]

Shah I, Khan SO, Malhotra S, Fischell T

Core Evidence 2014, 9:49-50

Published Date: 14 March 2014

Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis

Di Franco M, Gerardi MC, Lucchino B, Conti F

Core Evidence 2014, 9:41-48

Published Date: 12 March 2014

Micafungin: an evidence-based review of its place in therapy

de la Torre P, Reboli AC

Core Evidence 2014, 9:27-39

Published Date: 25 February 2014

Targeted therapy in triple-negative metastatic breast cancer: a systematic review and meta-analysis

Clark O, Botrel TE, Paladini L, Ferreira MB

Core Evidence 2014, 9:1-11

Published Date: 6 January 2014

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

Schaller SJ, Fink H

Core Evidence 2013, 8:57-67

Published Date: 25 September 2013

Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia

Chavez JC, Sahakian E, Pinilla-Ibarz J

Core Evidence 2013, 8:37-45

Published Date: 16 May 2013

Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer

Golshayan AR, Antonarakis ES

Core Evidence 2013, 8:27-35

Published Date: 4 April 2013

An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II

Floccard B, Hautin E, Bouillet L, Coppere B, Allaouchiche B

Core Evidence 2012, 7:105-114

Published Date: 27 September 2012

Pancrelipase: an evidence-based review of its use for treating pancreatic exocrine insufficiency

Nakajima K, Oshida H, Muneyuki T, Kakei M

Core Evidence 2012, 7:77-91

Published Date: 19 July 2012

Dapoxetine: an evidence-based review of its effectiveness in treatment of premature ejaculation

McCarty EJ, Dinsmore WW

Core Evidence 2012, 7:1-14

Published Date: 19 January 2012

Emerging role of carfilzomib in treatment of relapsed and refractory lymphoid neoplasms and multiple myeloma

Jain S, Diefenbach C, Zain J, O'Connor OA

Core Evidence 2011, 6:43-57

Published Date: 4 April 2011

Plerixafor for autologous CD34+ cell mobilization

Huda Salman, Hillard M Lazarus

Core Evidence 2011, 6:23-29

Published Date: 8 February 2011

Romidepsin: evidence for its potential use to manage previously treated cutaneous T cell lymphoma

Brian Poligone, Janet Lin, Catherine Chung

Core Evidence 2011, 6:1-12

Published Date: 22 December 2010

Dalfampridine sustained-release for symptomatic improvement of walking speed in patients with multiple sclerosis

Douglas R Jeffery, Emily Poole Pharr

Core Evidence 2010, 5:107-112

Published Date: 8 December 2010

Pitavastatin: evidence for its place in treatment of hypercholesterolemia

Peter Alagona, Jr

Core Evidence 2010, 5:91-105

Published Date: 22 October 2010

Panitumumab: the evidence for its use in the treatment of metastatic colorectal cancer

Rossana Berardi, Azzurra Onofri, Mirco Pistelli, et al

Core Evidence 2010, 5:61-76

Published Date: 24 September 2010

Dronedarone: evidence supporting its therapeutic use in the treatment of atrial fibrillation

Renee M Sullivan, Brian Olshansky

Core Evidence 2010, 5:49-59

Published Date: 15 September 2010

Pegylated interferon alpha-2b as adjuvant treatment of Stage III malignant melanoma: an evidence-based review

Sonia Okuyama, Rene Gonzalez, Karl D Lewis

Core Evidence 2010, 5:39-48

Published Date: 1 September 2010

Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Kristen Kulasa, Steven Edelman

Core Evidence 2010, 5:23-37

Published Date: 13 August 2010

Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis

Eliana Krulig, Kenneth B Gordon

Core Evidence 2010, 5:11-22

Published Date: 5 July 2010

Carbidopa/levodopa/entacapone: the evidence for its place in the treatment of Parkinson’s disease

Markos Poulopoulos, Cheryl Waters

Core Evidence 2010, 5:1-10

Published Date: 22 December 2009

Methylnaltrexone: the evidence for its use in the management of opioid-induced constipation

Peter Deibert, Carola Xander, Hubert E Blum, et al

Core Evidence 2009, 4:247-258

Published Date: 11 December 2009

Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy

Paul Richardson, Constantine Mitsiades, Jacob Laubach, et al

Core Evidence 2009, 4:215-245

Published Date: 17 November 2009

Nilotinib for the treatment of chronic myeloid leukemia: An evidence-based review

Elias Jabbour, Jorge Cortes, Hagop Kantarjian

Core Evidence 2009, 4:207-213

Published Date: 5 October 2009

Trabectedin: the evidence for its place in therapy in the treatment of soft tissue sarcoma

Katherine A Thornton

Core Evidence 2009, 4:191-198

Published Date: 21 August 2009

Agomelatine: The evidence for its place in the treatment of depression

Daniela Eser, Thomas C Baghai, Hans-Jürgen Möller

Core Evidence 2009, 4:171-179

Published Date: 5 August 2009

Etravirine (TMC-125): The evidence for its place in the treatment of HIV-1 infection

Hans-Jürgen Stellbrink

Core Evidence 2009, 4:149-158

Published Date: 22 July 2009

Raltegravir: The evidence of its therapeutic value in HIV-1 infection

Kavya Ramkumar, Nouri Neamati

Core Evidence 2009, 4:131-147

Published Date: 2 July 2009

Lasofoxifene: Evidence of its therapeutic value in osteoporosis

Luigi Gennari, Daniela Merlotti, Vincenzo De Paola, Ranuccio Nuti

Core Evidence 2009, 4:113-129

Published Date: 1 July 2009

Temozolomide: The evidence for its therapeutic efficacy in malignant astrocytomas

Ayman I Omar, Warren P Mason

Core Evidence 2009, 4:93-111

Published Date: 26 June 2009

Conivaptan: Evidence supporting its therapeutic use in hyponatremia

Melissa Li-Ng, Joseph G Verbalis

Core Evidence 2009, 4:83-92

Published Date: 25 June 2009

Desvenlafaxine in major depressive disorder: an evidence-based review of its place in therapy

Daniel Z Lieberman, Suena H Massey

Core Evidence 2009, 4:67-82

Published Date: 25 June 2009

Eptifibatide: The evidence for its role in the management of acute coronary syndromes

Ibrahim Shah, Shakeel O Khan, Surender Malhotra, Tim Fischell

Core Evidence 2009, 4:49-65

Published Date: 18 June 2009

Axitinib: The evidence of its potential in the treatment of advanced thyroid cancer

Hari A Deshpande, Scott Gettinger, Julie Ann Sosa

Core Evidence 2009, 4:43-48

Published Date: 10 June 2009

Indacaterol: a new once daily long-acting beta2 adrenoceptor agonist

Kai M Beeh, Jutta Beier

Core Evidence 2009, 4:37-41

Published Date: 18 June 2009

Febuxostat: the evidence for its use in the treatment of hyperuricemia and gout

Angelo L Gaffo, Kenneth G Saag

Core Evidence 2009, 4:25-36

Published Date: 23 June 2009

Exforge® (amlodipine/valsartan combination) in hypertension: the evidence of its therapeutic impact

Jean-Marie Krzesinski, Eric P Cohen

Core Evidence 2009, 4:1-11

Published Date: 17 June 2009

Ivabradine: the evidence of its therapeutic impact in angina

Guillaume Marquis-Gravel, Jean-Claude Tardif

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Omalizumab: the evidence for its place in the treatment of allergic asthma

Diarmuid M. McNicholl, Liam G. Heaney

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Prucalopride: the evidence for its use in the treatment of chronic constipation

Georges Coremans

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome

Arash Aghel, W. H. Wilson Tang

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus

Louise Profit, Paul Chrisp, Carole Nadin

Core Evidence 2008, 3:0-0

Published Date: 31 December 2008

Adalimumab in ankylosing spondylitis: an evidence-based review of its place in therapy

Stephanie Hennigan, Christoph Ackermann, Arthur Kavanaugh

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Anidulafungin: an evidence-based review of its use in invasive fungal infections

Susan L. Davis, Jose A. Vazquez

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Arzoxifene: the evidence for its development in the management of breast cancer

Lee R. Jackson, Kwok L. Cheung, Aman U. Buzdar, John F. R. Robertson

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Paliperidone: the evidence of its therapeutic value in schizophrenia

Joshua Kantrowitz, Leslie Citrome

Core Evidence 2007, 2:0-0

Published Date: 15 December 2007

Abatacept: the evidence for its place in the treatment of rheumatoid arthritis

Marcus D. Köller

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Rimonabant: the evidence for its use in the treatment of obesity and the metabolic syndrome

Mark Waterlow, Paul Chrisp

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Pioglitazone and metformin fixed-dose combination in type 2 diabetes mellitus: an evidence-based review of its place in therapy

Giuseppe Derosa, Sibilla Anna Teresa Salvadeo

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Eritoran: the evidence of its therapeutic potential in sepsis

Shahzad G. Raja, Gilles D. Dreyfus

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Certolizumab pegol: an evidence-based review of its place in the treatment of Crohn’s disease

Andrea Cassinotti, Sandro Ardizzone, Gabriele Bianchi Porro

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Infliximab: the evidence for its place in therapy in ulcerative colitis

Gert Van Assche, Séverine Vermeire, Paul Rutgeerts

Core Evidence 2007, 2:0-0

Published Date: 15 September 2007

Panitumumab: the evidence of its therapeutic potential in metastatic colorectal cancer care

Erika Martinelli, Floriana Morgillo, Teresa Troiani, Giampaolo Tortora, et al.

Core Evidence 2007, 2:0-0

Published Date: 15 June 2007

Lumiracoxib: the evidence of its clinical impact on the treatment of osteoarthritis

Louise Profit, Paul Chrisp

Core Evidence 2007, 2:0-0

Published Date: 15 June 2007

Capecitabine: an evidence-based review of its effectiveness in the treatment of carcinoma of the pancreas

David B. Smith, John P. Neoptolemos

Core Evidence 2007, 2:0-0

Published Date: 15 June 2007

Maraviroc: the evidence for its potential in the management of HIV

Louise Profit

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Bevacizumab: the evidence for its clinical potential in the treatment of nonsmall cell lung cancer

Sonya Haslam, Paul Chrisp

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Etanercept in psoriasis: the evidence of its therapeutic impact

Andrew Thomson

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Perindopril: the evidence of its therapeutic impact in hypertension

Andrew Thomson, Mary Greenacre

Core Evidence 2007, 2:0-0

Published Date: 15 March 2007

Eltrombopag: the emerging evidence of its therapeutic value in thrombocytopenia

Louise Profit

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Ciclesonide in persistent asthma: the evidence of its therapeutic value

Charlotte A. Kenreigh, Linda Timm Wagner, Paul Chrisp

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Aripiprazole: the evidence of its therapeutic impact in schizophrenia

William Winlow, Louise Profit, Paul Chrisp

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

Bortezomib: the evidence of its clinical impact in multiple myeloma

Simon Lancaster

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 30 June 2006

K-111: the emerging evidence for its potential in the treatment of the metabolic syndrome

Margaret Duggan-Keen

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 31 March 2006

FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value

Andrew Thomson

Core Evidence 2006, 1-Issues 3 & 4:0-0

Published Date: 31 March 2006

Lapatinib: the evidence for its therapeutic value in metastatic breast cancer

Andrew Thomson

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Exubera® (inhaled insulin): an evidence-based review of its effectiveness in the management of diabetes

Louise Profit

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Topiramate: the evidence for its therapeutic value in the prevention of migraine

Carole Nadin

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Dutasteride: an evidence-based review of its clinical impact in the treatment of benign prostatic hyperplasia

Andrew Thomson

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Eplerenone: the evidence for its place in the treatment of heart failure after myocardial infarction

Carole Nadin

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 30 June 2005

Dasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia

Sonya Haslam

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005

Aliskiren in hypertension: evidence for its potential therapeutic value

Doris Peter

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005

Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease

Linda Timm Wagner, Charlotte A. Kenreigh

Core Evidence 2005, 1-Issues 1 & 2:0-0

Published Date: 31 March 2005